Perindopril (Coversyl) Tablet Uses in Pakistan

Perindopril (Coversyl) is used in Pakistan for blood pressure, heart disease, stroke prevention, and kidney protection. The EUROPA and PROGRESS trials have proven its particular benefit in coronary artery disease and stroke prevention. All its uses are detailed in this guide.

Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated: 2026-06-17

Uses

Quick Answer

Perindopril (Coversyl) is an ACE inhibitor with the strongest clinical trial evidence for stable coronary artery disease (EUROPA trial: 20% CV event reduction), stroke prevention with indapamide (PROGRESS trial), and diabetic outcomes (ADVANCE trial). Also used for hypertension, heart failure, and post-MI secondary prevention. Once daily dosing. ACE inhibitor cough (dry persistent cough) affects 20-30% South Asians — switch to ARB if intolerable. Angioedema is rare but a life-threatening emergency — stop drug immediately.

Primary Uses at a Glance

Hypertension — Blood Pressure Control

Perindopril is an ACE inhibitor for primary and secondary hypertension. It blocks the ACE enzyme — converting Angiotensin I to II is prevented — and blood pressure falls. It is a long-acting formulation — once daily is adequate. Particularly preferred in diabetics, CKD, post-MI, and CAD patients.

Once daily — morning preferred. Doctor titrates the dose. Check renal function and potassium 1-2 weeks later.

Stable Coronary Artery Disease (CAD) — EUROPA Trial

Perindopril has the strongest RCT evidence in stable CAD. The EUROPA trial (9,000+ patients, 2003) proved: perindopril 8mg daily gave a 20% relative risk reduction in CV death, MI, and cardiac arrest — in stable CAD patients even with normal BP. This is what makes this medicine preferred in CAD.

8mg once daily (target dose — EUROPA trial dose). Doctor-prescribed — long-term use.

Stroke Prevention — PROGRESS Trial (With Indapamide)

The PROGRESS trial (2001) showed that perindopril + indapamide combination reduced recurrent stroke risk by 28% (combination arm — 43%) in post-stroke patients. Coversyl Plus (perindopril + indapamide fixed-dose combo) is this combination — widely prescribed for stroke prevention.

Perindopril with or without indapamide — doctor decides combination or monotherapy.

Heart Failure (Systolic)

In heart failure with reduced ejection fraction (HFrEF), perindopril is core ACEi therapy. RAAS blockade reduces the load on the heart, prevents remodelling, and improves prognosis — a class effect of all ACEi.

Start at 2mg — titrate up under cardiologist supervision.

Post-MI Secondary Prevention

After a heart attack (MI), perindopril is used for secondary prevention — it prevents LV remodelling and reduces mortality. Confirmed post-MI benefit is a class effect of ACEi.

As prescribed by cardiologist. Long-term use.

Diabetic Nephropathy — Kidney Protection

In diabetes, ACE inhibitors are renoprotective — they reduce proteinuria and slow CKD progression. In the ADVANCE trial, perindopril + indapamide combination improved macrovascular and microvascular outcomes in diabetics.

As prescribed — even at normal BP in diabetics with proteinuria.

Other Uses

Non-diabetic proteinuric CKD — renoprotection
Hypertension in CKD (ACEi/ARB preferred)
Scleroderma renal crisis (specialist)

Perindopril (Coversyl) Tablet Uses (Fayde / Kis kaam aata hai)

Perindopril (Coversyl) contains Perindopril as the active ingredient and belongs to the ACE Inhibitor class. It is widely used in Pakistan for BP, heart disease, and stroke prevention.

Primary Uses (Mukhya Istemal)

Hypertension — blood pressure control
Stable Coronary Artery Disease — EUROPA trial (20% CV events reduction)
Stroke Prevention — PROGRESS trial with indapamide
Heart failure (systolic / HFrEF)
Post-MI secondary prevention
Diabetic nephropathy — renoprotection (ADVANCE trial)

Clinical Trial Evidence (Klinical Proof)

Trial	Patients	Finding
EUROPA (2003)	9,000+ stable CAD	20% reduction CV death/MI/arrest
PROGRESS (2001)	Post-stroke	28% recurrent stroke reduction (combination arm 43%)
ADVANCE (2007)	Diabetics	Macro + microvascular outcomes improved

Coversyl Plus — Combination Tablet

Perindopril + Indapamide fixed-dose combination — PROGRESS/ADVANCE trial protocol. Prescribed for post-stroke patients and diabetics.

ACE Inhibitor Class Notes

Property	Detail
Dry cough	Occurs — in 20-30% South Asians; not an allergy
Angioedema	Rare but EMERGENCY — STOP drug
Renal monitoring	Creatinine + potassium after 1-2 weeks
Pregnancy	CONTRAINDICATED — Category D

When NOT to Use

PREGNANCY (Category D)
Prior angioedema with ACEi
Bilateral renal artery stenosis
Severe hyperkalemia

The information in this guide is for educational purposes only.

Frequently Asked Questions

Perindopril kis kaam aata hai?

Perindopril (Coversyl) is used for BP control, stable CAD (EUROPA trial), stroke prevention (PROGRESS trial with indapamide), heart failure, post-MI protection, and diabetic nephropathy. It is an ACE Inhibitor class medicine.

Perindopril dil ki bimari mein kyun prefer kiya jata hai?

Perindopril has the strongest evidence in stable coronary artery disease (CAD) from the EUROPA trial — 20% CV events reduction in 9,000+ patients with stable CAD. The PROGRESS trial covers stroke prevention. These trials make it the preferred ACEi in CAD and stroke prevention.

Coversyl Plus kya hai?

Coversyl Plus is a fixed-dose combination tablet of perindopril + indapamide (diuretic). The PROGRESS trial proved this combination effective for stroke prevention — in post-stroke patients and diabetics. Both medicines are in one tablet — making adherence easier.

Perindopril aur ramipril mein farq kya hai?

Both are ACEi — ramipril has HOPE trial evidence in post-MI. Perindopril has more data in stable CAD (EUROPA) and stroke prevention (PROGRESS). Both are effective — the doctor chooses based on clinical indication.

Perindopril se khansi hoti hai — kya alternative hai?

Yes — perindopril causes a dry persistent cough (due to bradykinin). If intolerable, the doctor switches to an ARB (olmesartan, losartan, valsartan, telmisartan) — same BP and renal benefits, no cough. Do not stop on your own — see your doctor.

Brand alternatives, same-class options, and other medicines used for the same conditions as Perindopril Tablet.

Other arbs, ace inhibitors and other bp medicines

Sibling medicines in the ARBs, ACE Inhibitors and Other BP Medicines class.

All in class →

Used for the same conditions

Other medicines commonly used for headache and overlapping conditions.

Headache hub →

Sources

DRAP Registered Products Database — Drug Regulatory Authority of Pakistan
WHO Model List of Essential Medicines, 23rd ed. (2023) — World Health Organization
British National Formulary (BNF) — BMJ Group & Pharmaceutical Press

Medical disclaimer

This page is for educational use only and does not replace professional medical advice. Always confirm diagnosis, dose, and interactions with a qualified doctor or pharmacist before starting or changing any medicine.